![18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis | Annals of the Rheumatic Diseases 18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/78/5/657/F1.large.jpg?width=800&height=600&carousel=1)
18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis | Annals of the Rheumatic Diseases
![Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology](https://www.thelancet.com/cms/attachment/bd645874-312e-4be0-b348-c647904c99b2/gr1.jpg)
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology
![NCA Research NHS on X: "Significant publication here in inclusion body myositis - good to see the role of patient representatives in highlighting understudied symptoms and need for a timely diagnosis. 1st NCA Research NHS on X: "Significant publication here in inclusion body myositis - good to see the role of patient representatives in highlighting understudied symptoms and need for a timely diagnosis. 1st](https://pbs.twimg.com/media/GIuydaPWMAAnRxl.png)